logo for the Common Good seriesThe Common Good is a quarterly series hosted by the PCDC. We’re inviting thought leaders from across the fields of oncology, clinical trials, and international data sharing to talk about big ideas that can redefine how we think about cancer research and treatment. The more we learn from each other, the better we can all work toward the common good.


Putting Children First:
New Models for Pediatric Oncology Drug Development

Sam Blackman, MD, PhD
Tuesday, January 25, 2022

11:00am Central Time

Join Sam Blackman, co-founder and Chief Medical Officer of Day One Biopharmaceuticals, for a discussion of how pediatric oncology drug development can change for the better. Dr. Blackman, who has led the early clinical development of more than 10 novel cancer therapeutics, will describe the challenges that have limited the pace of development of new therapeutics for pediatric cancer, new business models that may be capable of changing this dynamic, and how the pediatric oncology ecosystem can work together to enable success.


2020 Vision: The Future of Clinical Trials Is Here. Are We?

Greg Simon, former President of the Biden Cancer Initiative, describes the recent progress made in patient-friendly clinical trials and the need to retain these changes to increase diversity and equity and to lessen the burden on patients wherever possible. Having leapt ten years ahead due to Covid, let’s not go back to 2019. Presented on October 27, 2021.

Be the first to know about future talks in this series by signing up for the PCDC email list!

The views and opinions expressed in Common Good talks are those of the speakers and do not necessarily reflect the official policy or position of the Pediatric Cancer Data Commons or the University of Chicago.